GlassScriptPhysician profile
Judith A Cagan
NPI 1194808923
$1,117.65
in general payments reported to CMS, 2019-2025
20 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $28.86 · 2021: $223 · 2022: $201 · 2024: $164 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $266.42 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $100.59 | 2021-2025 | Rybelsus, Ozempic |
| Mallinckrodt Hospital Products INC. | $94.22 | 2022-2024 | Acthar |
| Celgene Corporation | $92.95 | 2024-2025 | Reblozyl |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.12 | 2021-2025 | Jardiance, Cyltezo |
| Merck Sharp & Dohme LLC | $63.07 | 2019-2025 | Capvaxive, Gardasil 9 |
| Lilly USA, LLC | $62.84 | 2021-2025 | Jardiance |
| Abbvie INC. | $56.44 | 2019 | |
| Ani Pharmaceuticals, INC. | $34.16 | 2025 | Purified Cortrophin Gel |
| Octapharma USA, INC. | $33.99 | 2024 | Octagam Immune Globulin (Human) |
| Dynavax Technologies Corporation | $29.71 | 2022 | |
| Abiomed | $28.36 | 2025 | |
| Janssen Biotech, INC. | $27.92 | 2021 | |
| Qiagen, LLC | $22.10 | 2025 | |
| Hologic Sales and Service, LLC | $22.04 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $21.49 | 2025 | Zoryve |
| Abbott Laboratories | $19.34 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.72 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $17.98 | 2022 | |
| Glaxosmithkline, LLC. | $17.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Cagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.